MVM Partners, LLC

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 1, 2024), MVM Partners, LLC reported 3 stock positions worth $91.7 million. Its top holding was Paragon 28 (FNA) at 79.0% of the portfolio, followed by Mdxhealth (MDXH, 10.6%) and Optinose (10.4%). Compared with Q2 2024, it added to 1. The biggest buy was Mdxhealth (MDXH, shares +3%).

Most Recent 13F
Q2 2026
Location
BOSTON, MA
CIK
0001947083
Portfolio Value
$91.7M (Q3 2024)
SEC Filing
0002039852-24-000036 ↗ filed Nov 1, 2024

Holdings Value

0$50.0M$100.0M$150.0M$200.0M Q1 2024: $167.1M Q1 2024 Q2 2024: $99.9M Q2 2024 Q3 2024: $91.7M $91.7M Q3 2024 Q4 2024: $124.4M Q4 2024 Q1 2025: $78.9M Q1 2025 Q2 2025: $10.3M Q2 2025 Q3 2025: $21.8M Q3 2025 Q4 2025: $16.8M Q4 2025 Q1 2026: $10.8M Q1 2026 Q2 2026: $1.9M Q2 2026

Holdings 3 stocks · $91.7M

FNA Paragon 28 Inc. 79.02% 10,886,145 $72.4M No change
MDXH Mdxhealth 10.59% 4,700,457 $9.7M Add +3.3%
OPTINOSE INC 10.40% 14,605,263 $9.5M No change

Portfolio Sells Q2 2024 → Q3 2024

None this quarter.

Portfolio Buys Q2 2024 → Q3 2024

MDXH Mdxhealth Add +3.3% 10.59% +0.06

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$1.9MMDXH
Q1 2026 1$10.8MMDXH
Q4 2025 1$16.8MMDXH
Q3 2025 1$21.8MMDXH
Q2 2025 1$10.3MMDXH
Q1 2025 3$78.9MFNA, OPTINOSE INC, MDXH
Q4 2024 3$124.4MFNA, MDXH, OPTINOSE INC
Q3 2024 3$91.7MFNA, MDXH, OPTINOSE INC
Q2 2024 3$99.9MFNA, OPTINOSE INC, MDXH
Q1 2024 3$167.1MFNA, OPTINOSE INC, MDXH